InvestorsHub Logo

Investor2014

11/20/23 9:10 AM

#439361 RE: sokol #439352

I think EMA is the smarter route too. Better with a first approval, than hanging on for a potentially higher pricing precedence on the hope of FDA approval.

sab63090

11/20/23 10:58 AM

#439430 RE: sokol #439352

Sokol:

Your post is the most logical opinion & I would just assume that Missling is more informed about the peer review timeline than anyone here...I like the fact from a technical viewpoint that we gapped up and I am targeting, at least, the 200 day for now which hits today at $8.12, but there is resistance there, volume is confirming and I think we shoot up past the $8 dollar level towards $9.50 as next resistance.

I now try to avoid the finger pointing and rather scan here from time to time! I never get too excited, since the market has a way of slapping those over confident.

2 Fan Lines have been broken and working soon on the third.

Joseph_K

11/20/23 11:12 AM

#439441 RE: sokol #439352

Actually, this applies to the USA, too:

ARIA "requires constant and repeated MRI examination, for which not all regions in Europe are currently sufficiently prepared and equipped for in addition to the requirement to address affordability and inequalities in patient access within European Union countries.”